scispace - formally typeset
M

Mohamed Marzouk

Researcher at Salman bin Abdulaziz University

Publications -  11
Citations -  189

Mohamed Marzouk is an academic researcher from Salman bin Abdulaziz University. The author has contributed to research in topics: Biological activity & Candida tropicalis. The author has an hindex of 7, co-authored 11 publications receiving 119 citations.

Papers
More filters
Journal ArticleDOI

Synthesis and anticancer activity of new quinazoline derivatives

TL;DR: A new series of quinazoline derivatives was synthesized and characterized via physicochemical and spectral means and exhibited significant in vitro cytotoxicity against both HeLa and MDA-MB231 cancer cell lines.
Journal ArticleDOI

Screening and evaluation of antioxidant activity of some 1,2,4-triazolo[1,5-a]quinazoline derivatives.

TL;DR: The obtained findings revealed that the triazoloquinazolines 30, 36 and 38-40 have superiority among all compounds, demonstrating the highest capacity to deplete 1,1-diphenyl-2-picryl hydrazyl and free radicals, in relation to butylated hydroxyl toluene, as a synthetic antioxidant agent.
Journal ArticleDOI

In vitro evaluation of new 2-phenoxy-benzo[g][1,2,4]triazolo[1,5-a]quinazoline derivatives as antimicrobial agents

TL;DR: It is shown that some benzo[g]traizoloquinazolines displayed remarkable antimicrobial activity and could be used as template for further design of potent antimicrobial agent.
Journal ArticleDOI

3-Benzyl(phenethyl)-2-thioxobenzo[g]quinazolines as a new class of potent α-glucosidase inhibitors: synthesis and molecular docking study.

TL;DR: A new class of potent α-glucosidase inhibitors was identified, and the molecular docking predicted plausible binding interaction of the targets in the binding pocket of α- glucose and rationalized the structure-activity relationship (SARs) of the target compounds.
Journal ArticleDOI

Synthesis, crystallographic characterization, molecular docking and biological activity of isoquinoline derivatives

TL;DR: The obtained results indicate promising anti-arthritic activity for compounds 9 and 15 as significant reduction of the serum level of interleukin-1 β [IL-1β], cyclooxygenase-2 [COX-2] and prostaglandin E2 [PGE2] was observed in CFA rats.